Lataa...
Endostatin and Oxaliplatin‐Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study
LESSONS LEARNED. Definitive concurrent chemoradiotherapy based on oxaliplatin and endostatin was effective with the objective response rate exceeding 80%, and the treatment‐related toxicities were acceptable. The treatment compliance of the current combination was much higher, without significant re...
Tallennettuna:
| Julkaisussa: | Oncologist |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6459259/ https://ncbi.nlm.nih.gov/pubmed/30850562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0119 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|